Cancer Biotechnology

Research focused on understanding the molecular mechanisms of cancer, and developing diagnostics and drugs for its cure. The most cross-disciplinary of contemporary research areas, cancer Biotechnology research includes scientists from medicine, biology, physics and engineering disciplines. Today, oncologists can personalize treatment plans using information found within patients' own genetic codes. They can target specific DNA mutations found in tumors themselves, and they can empower some patients' own immune systems to attack cancer cells. As a possible new technology for cancer treatment, gene editing with CRISPR takes months, not a year or two, to genetically modify T cells. That may mean much faster treatment for patients. The potential for genetic medicine is ground breaking. Altering parts of DNA can redefine how your body fights off cancer.

    Related Conference of Cancer Biotechnology

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Cancer Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in